http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2010008531-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
filingDate 2009-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9a23d1b024c62591c434615e4e8206b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c9414b3a27a24ff5a22eba07f2b4c09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e3e4bc17ca27014be3d30663d3a9b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cdf2f38836cb219e907f28f48decaba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ff1341512a953b658c1c11cceb70ee1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbe8dc04241d4ed47d74dcaae607b097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0358873d115c3de0e3eb6c850da8ced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bad5d4263b43d799bbbe6912f9028dc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_401e35e72cae39c76fde88366eb272b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb0c757fe2e56dee0f67895a8bf62b58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dca6dc14ae8c1bfb3e0a1c5e7f6c794f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd51250aded4d1b38bc5b899ef5c52cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eede9690038273e83d5a87c0f3e5718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c693c8a953c4e4010af4611467d68e69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a5a01a69280c60837af05a942c893e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42eb2d757b504662a2fed57567fc2b6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1dafb5b25f87607cdca9031497705f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc593327478e13e9b15a61e2f5c94181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93865dc7e441cb3d6820c741a3579929
publicationDate 2010-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2010008531-A
titleOfInvention BIFENYLL DERIVATIVES CONFORMALLY RESTRICTED FOR USE AS INHIBITORS OF HEPATITIS VIRUS C.
abstract The present description relates to compounds, compositions and methods for the therapy of hepatitis C virus (HCV) infection. Pharmaceutical compositions containing such compounds and methods for using these compounds in HCV infection therapy are also described.
priorityDate 2008-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7095

Total number of triples: 41.